Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

BACKGROUND/AIMS: Adefovir dipivoxil (ADV) is a nucleotide analogue that is effective against lamivudine-resistant hepatitis B virus (HBV). The aim of this study was to determine the long-term clinical outcomes after ADV rescue therapy in decompensated patients infected with lamivudine-resistant HBV....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Woo, Hyun Young, Choi, Jong Young, Yoon, Seung Kew, Suh, Dong Jin, Paik, Seung Woon, Han, Kwang Hyub, Um, Soon Ho, Kim, Byung Ik, Lee, Heon Ju, Cho, Mong, Lee, Chun Kyon, Kim, Dong Joon, Hwang, Jae Seok
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association for the Study of the Liver 2014
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4099332/
https://ncbi.nlm.nih.gov/pubmed/25032183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2014.20.2.168
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados